Concerns regarding toxicity associated with caffeine-containing pre-workout supplements
DOI:
https://doi.org/10.7196/SAMJ.2026.v116i6.5186Keywords:
caffeine, pre-workout supplements, toxicityAbstract
-
References
1. Jagim A, Harty P, Camic C. Common ingredient profiles of multi-ingredient pre-workout supplements.
Nutrients 2019;11(2):254. https://doi.org/10.3390/nu11020254
2. Desbrow B, Hall S, O’Connor H, et al. Caffeine content of pre-workout supplements commonly used by
Australian consumers. Drug Test Anal 2019;11(3):523-529. https://doi.org/10.1002/dta.2501
3. Harris B, Winn C, Ableman T. Hemorrhagic stroke in a young healthy male following use of pre-workout
supplement Animal Rage XL. Military Med 2017;182(9-10):e2030-e2033. https://doi.org/10.7205/
MILMED-D-17-00013
4. Kamijo Y, Takai M, Fujita Y, et al. A retrospective study on the epidemiological and clinical features of
emergency patients with large or massive consumption of caffeinated supplements or energy drinks in
Japan. Intern Med 2018;57(15):2141-2146. https://doi.org/10.2169/internalmedicine.0333-17
5. National Department of Health, South Africa. Medicines and Related Substances Act No. 1010 of
1965. Consolidated Schedules 1 August 2025.Goverment Gazette No. 53099: 6464. 2025. https://www.
sahpra.org.za/wp-content/uploads/2025/08/Consolidated-Schedules_01-August-2025.pdf (accessed
18 June 2026).
6. South African Health Products Regulatory Authority. Complementary medicines guidance on specified
substances. Pretoria: SAHPRA, 2022. https://www.sahpra.org.za/wp-content/uploads/2022/02/7.06_
CMs_Specified_Substances_Jan22_v3_2.pdf (accessed 18 June 2026).
7. Garthe I, Maughan R. Athletes and supplements: Prevalence and perspectives. Int J Sport Nutr Exercise
Metab 2018;28(2):126-138. https://doi.org/10.1123/ijsnem.2017-0429
Additional Files
Published
Issue
Section
License
Copyright (c) 2026 J Taylor, G Tatz, N Madikizela, M Blockman

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Licensing Information
The SAMJ is published under an Attribution-Non Commercial International Creative Commons Attribution (CC-BY-NC 4.0) License. Under this license, authors agree to make articles available to users, without permission or fees, for any lawful, non-commercial purpose. Users may read, copy, or re-use published content as long as the author and original place of publication are properly cited.
Exceptions to this license model is allowed for UKRI and research funded by organisations requiring that research be published open-access without embargo, under a CC-BY licence. As per the journals archiving policy, authors are permitted to self-archive the author-accepted manuscript (AAM) in a repository.
Publishing Rights
Authors grant the Publisher the exclusive right to publish, display, reproduce and/or distribute the Work in print and electronic format and in any medium known or hereafter developed, including for commercial use. The Author also agrees that the Publisher may retain in print or electronic format more than one copy of the Work for the purpose of preservation, security and back-up.





